Literature DB >> 21396916

Subsite specificity of anthrax lethal factor and its implications for inhibitor development.

Feng Li1, Simon Terzyan, Jordan Tang.   

Abstract

The lethal factor of Bacillus anthracis is a major factor for lethality of anthrax infection by this bacterium. With the aid of the protective antigen, lethal factor gains excess to the cell cytosol where it manifests toxicity as a metalloprotease. For better understanding of its specificity, we have determined its residue preferences of 19 amino acids in six subsites (from P3 to P3') as relative k(cat)/K(m) values (specificity constants). These results showed that lethal factor has a broad specificity with preference toward hydrophobic residues, but not charged or branched residues. The most preferred residues in these six subsites are, from P1 to P3', Trp, Leu, Met, Tyr, Pro, and Leu. The result of residue preference was used to design new substrates with superior hydrolytic characteristics and inhibitors with high potency. For better use of the new findings for inhibitor design, we have modeled the most preferred residues in the active site of lethal factor. The observed interactions provide new insights to future inhibitor designs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396916      PMCID: PMC3104405          DOI: 10.1016/j.bbrc.2011.03.033

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Crystal structure of the anthrax lethal factor.

Authors:  A D Pannifer; T Y Wong; R Schwarzenbacher; M Renatus; C Petosa; J Bienkowska; D B Lacy; R J Collier; S Park; S H Leppla; P Hanna; R C Liddington
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

Review 2.  Molecular recognitions in the MAP kinase cascades.

Authors:  Takuji Tanoue; Eisuke Nishida
Journal:  Cell Signal       Date:  2003-05       Impact factor: 4.315

3.  The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor.

Authors:  Benjamin E Turk; Thiang Yian Wong; Robert Schwarzenbacher; Emily T Jarrell; Stephen H Leppla; R John Collier; Robert C Liddington; Lewis C Cantley
Journal:  Nat Struct Mol Biol       Date:  2003-12-29       Impact factor: 15.369

4.  The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited.

Authors:  Fiorella Tonello; Paolo Ascenzi; Cesare Montecucco
Journal:  J Biol Chem       Date:  2003-07-29       Impact factor: 5.157

Review 5.  Anthrax toxin: a tripartite lethal combination.

Authors:  Paolo Ascenzi; Paolo Visca; Giuseppe Ippolito; Andrea Spallarossa; Martino Bolognesi; Cesare Montecucco
Journal:  FEBS Lett       Date:  2002-11-20       Impact factor: 4.124

Review 6.  Anthrax.

Authors:  M Mock; A Fouet
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

7.  Proteolytic activation of recombinant pro-memapsin 2 (pro-beta-secretase) studied with new fluorogenic substrates.

Authors:  J Ermolieff; J A Loy; G Koelsch; J Tang
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

8.  Screening inhibitors of anthrax lethal factor.

Authors:  Fiorella Tonello; Michela Seveso; Oriano Marin; Michèle Mock; Cesare Montecucco
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

9.  Specificity of memapsin 1 and its implications on the design of memapsin 2 (beta-secretase) inhibitor selectivity.

Authors:  Robert T Turner; Jeffrey A Loy; Chan Nguyen; Thippeswamy Devasamudram; Arun K Ghosh; Gerald Koelsch; Jordan Tang
Journal:  Biochemistry       Date:  2002-07-09       Impact factor: 3.162

10.  Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.

Authors:  A Jane Bardwell; Mahsa Abdollahi; Lee Bardwell
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

View more
  7 in total

1.  Inhibition of anthrax lethal factor: lability of hydroxamate as a chelating group.

Authors:  Feng Li; Irina Chvyrkova; Simon Terzyan; Nancy Wakeham; Robert Turner; Arun K Ghosh; Xuejun C Zhang; Jordan Tang
Journal:  Appl Microbiol Biotechnol       Date:  2012-01-25       Impact factor: 4.813

2.  Enterococcus faecalis PrgJ, a VirB4-like ATPase, mediates pCF10 conjugative transfer through substrate binding.

Authors:  Feng Li; Cristina Alvarez-Martinez; Yuqing Chen; Kyoung-Jae Choi; Hye-Jeong Yeo; Peter J Christie
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

3.  Development of a comprehensive, validated pharmacophore hypothesis for anthrax toxin lethal factor (LF) inhibitors using genetic algorithms, Pareto scoring, and structural biology.

Authors:  Ting-Lan Chiu; Elizabeth A Amin
Journal:  J Chem Inf Model       Date:  2012-06-25       Impact factor: 4.956

Review 4.  Inhibitors of the Metalloproteinase Anthrax Lethal Factor.

Authors:  Allison B Goldberg; Benjamin E Turk
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 5.  Manipulation of kinase signaling by bacterial pathogens.

Authors:  Anne Marie Krachler; Andrew R Woolery; Kim Orth
Journal:  J Cell Biol       Date:  2011-11-28       Impact factor: 10.539

Review 6.  Antibiotic Discovery and Resistance: The Chase and the Race.

Authors:  Katia Iskandar; Jayaseelan Murugaiyan; Dalal Hammoudi Halat; Said El Hage; Vindana Chibabhai; Saranya Adukkadukkam; Christine Roques; Laurent Molinier; Pascale Salameh; Maarten Van Dongen
Journal:  Antibiotics (Basel)       Date:  2022-01-30

Review 7.  Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor.

Authors:  Catherine H Schein; Deliang Chen; Lili Ma; John J Kanalas; Jian Gao; Maria Estrella Jimenez; Laurie E Sower; Mary A Walter; Scott R Gilbertson; Johnny W Peterson
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.